NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
key details
| Value | £37,954,000 (£45,544,800 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West |
| Deadline | 31 Oct 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-05936a |
Awards (17)
This procurement was awarded to 9 suppliers. Values shown are per-award; the notice total is £37,954,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD shared | £25,881,000 | 25 Nov 2025 | pending |
| ACCORD-UK LTD shared | · | · | active |
| AMAROX LIMITED shared | · | · | active |
| CELIX PHARMA LTD shared | £25,881,000 | 25 Nov 2025 | pending |
| CELIX PHARMA LTD shared | · | · | active |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £25,881,000 | 25 Nov 2025 | pending |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | · | · | active |
| Farmak Pharmaceuticals UK Ltd shared | £25,881,000 | 25 Nov 2025 | pending |
| Farmak Pharmaceuticals UK Ltd shared | · | · | active |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED shared | £25,881,000 | 25 Nov 2025 | pending |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED shared | · | · | active |
| TEVA UK LIMITED shared | £25,881,000 | 25 Nov 2025 | pending |
| TEVA UK LIMITED shared | · | · | active |
| THORNTON & ROSS LIMITED shared | £25,881,000 | 25 Nov 2025 | pending |
| THORNTON & ROSS LIMITED shared | · | · | active |
| ZENTIVA PHARMA UK LIMITED shared | £25,881,000 | 25 Nov 2025 | pending |
| ZENTIVA PHARMA UK LIMITED shared | · | · | active |
description
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026
Offer reference number: CM/TNS/25/5735
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)
Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
documents
- https://www.find-tender.service.gov.uk/Notice/061712-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5787 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5788 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5789 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5790 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5791 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5792 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5793 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5794 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5795 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5796 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5797 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5798 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Sept 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 053638-2025 |
| 2 Oct 2025 | Tender notice (UK4) | Procurement Act 2023 | 061712-2025 |
| 26 Nov 2025 | Contract award (UK6) | Procurement Act 2023 | 077377-2025 |
| 30 Jan 2026 | Contract details (UK7) | Procurement Act 2023 | 008310-2026 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.